These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 5326211)

  • 1. [Transfusion of human leukocytes. I. Critical review with emphasis on therapeutic use].
    Libánský J
    Cas Lek Cesk; 1966 Apr; 105(13):329-32. PubMed ID: 5326211
    [No Abstract]   [Full Text] [Related]  

  • 2. From leukocyte reduction to leukocyte transfusion: the immunological effects of transfused leukocytes.
    Lee JH; Klein HG
    Baillieres Best Pract Res Clin Haematol; 2000 Dec; 13(4):585-600. PubMed ID: 11102278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse effects of transfusions caused by leukocytes.
    Raife TJ
    J Intraven Nurs; 1997; 20(5):238-44. PubMed ID: 9369624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Radiophosphorus labeling of human leukocytes; transfusion into humans and animals; results of 3 years of testing].
    MAUPIN B; LOVERDO A; CHARY R; THEILLEUX R; STORCK J
    Rev Pathol Gen Physiol Clin; 1955 Mar; 55(666):450-65. PubMed ID: 14396059
    [No Abstract]   [Full Text] [Related]  

  • 5. Leukocyte depletion for safe blood transfusion.
    Singh S; Kumar A
    Biotechnol J; 2009 Aug; 4(8):1140-51. PubMed ID: 19418471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Transfusion of human leukocytes. II. Physician's responsibility when performing such transfusions in clinical practice].
    Dobrý E
    Cas Lek Cesk; 1966 Sep; 105(40):1090-1. PubMed ID: 5331520
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunological reactions secondary to blood transfusion.
    Flohé S; Kobbe P; Nast-Kolb D
    Injury; 2007 Dec; 38(12):1405-8. PubMed ID: 18048035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Appearance of iso-antibodies against the blood platelets, leukocytes and erythrocytes after blood transfusion].
    WALEWSKA I; GULMANTOWICZ A; KACPERSKA E; FRANKOWSKA K; CHOJNACKA I; KALINSKA J; SENDYSN
    Pol Tyg Lek; 1961 Aug; 16():1262-7. PubMed ID: 14004546
    [No Abstract]   [Full Text] [Related]  

  • 9. [The chronoresistance in vitro of leukocytes in the blood of subjects studied during reactions caused by total blood transfusion].
    CONFALONIERI C; NATANGELO R; NERI G; GRIFONI V
    Riv Emoter Immunoematol; 1959; 6():311-22. PubMed ID: 13695005
    [No Abstract]   [Full Text] [Related]  

  • 10. Issues in transfusion therapy in the patient with malignancy.
    Friedberg RC
    Hematol Oncol Clin North Am; 1994 Dec; 8(6):1223-53. PubMed ID: 7860446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Preservation of an erythrocyte concentrate with leukocytes and thrombocytes removed (isolation methods and the transfusion advantages)].
    Agranenko VA; Strauss D; Markova NA; Berndsen G; Poliakova LP
    Probl Gematol Pereliv Krovi; 1980 Sep; 25(9):15-9. PubMed ID: 7422638
    [No Abstract]   [Full Text] [Related]  

  • 12. Pneumonia as a complication of blood product transfusion in the critically ill: transfusion-related immunomodulation (TRIM).
    Vamvakas EC
    Crit Care Med; 2006 May; 34(5 Suppl):S151-9. PubMed ID: 16617260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonhemolytic transfusion reactions: reducing the incidence with leukocyte-poor red blood cells.
    Lichtiger B; Osier LE
    South Med J; 1983 Mar; 76(3):419. PubMed ID: 6828921
    [No Abstract]   [Full Text] [Related]  

  • 14. [Transfusion of leukocyte-deficient blood].
    Jorgensen JR
    Ugeskr Laeger; 1965 Sep; 127(37):1158-63. PubMed ID: 5868031
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of two types of leukocyte removal filters on transfusion dependent thalassaemics.
    Jamal R; Mazeni NR; Hussin H
    Malays J Pathol; 2000 Dec; 22(2):79-83. PubMed ID: 16329539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of leukoreduced blood transfusion on infection risk following injury: a randomized controlled trial.
    Nathens AB; Nester TA; Rubenfeld GD; Nirula R; Gernsheimer TB
    Shock; 2006 Oct; 26(4):342-7. PubMed ID: 16980879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Filtering white cells from blood for transfusion.
    Smith R
    BMJ; 1993 Mar; 306(6881):810. PubMed ID: 8490371
    [No Abstract]   [Full Text] [Related]  

  • 18. The clinical benefits of the leukoreduction of blood products.
    Blajchman MA
    J Trauma; 2006 Jun; 60(6 Suppl):S83-90. PubMed ID: 16763486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The use of transfusion of freshly preserved blood and leukocytes in patients with tumors of the female genitalia during radiotherapy].
    Zhavoronkova LA; Katulkina NN; Kovalevskaia TN; Litvina NM; Makarova IA; Tregubova NN; Khait MM; Iastrebenetskaia MM
    Med Radiol (Mosk); 1966 Mar; 11(3):40-4. PubMed ID: 5984482
    [No Abstract]   [Full Text] [Related]  

  • 20. Impact of transfusion on viral load in human immunodeficiency virus infection.
    Groopman JE
    Semin Hematol; 1997 Jul; 34(3 Suppl 2):27-33. PubMed ID: 9253781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.